| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Solar | 7.7 | 15.3 | 51.0 | | | |
| Biomedical | 6.9 | 6.9 | 7.8 | | | |
| Optoelectronics | | | | | | 65.0 |
| Total revenues [+] | 14.6 | 22.1 | 58.7 | 79.8 | 69.9 | 65.0 |
| Products | 5.7 | 13.0 | 50.7 | 66.7 | | |
| Services | 8.8 | 9.1 | 8.0 | 13.1 | | |
| Revenue growth [+] | -34.1% | -62.4% | -26.4% | 14.3% | 7.6% | |
| Solar | -49.8% | -70.1% | | | | |
| Biomedical | 1.1% | -11.9% | | | | |
| Cost of goods sold [+] | 12.1 | 16.8 | 44.8 | 65.2 | 63.4 | 45.6 |
| Cost of product sales | 7.5 | 11.9 | 40.2 | 55.2 | | |
| Cost of services | 4.6 | 4.9 | 4.6 | 10.0 | | |
| Gross profit | 2.5 | 5.3 | 14.0 | 14.7 | 6.5 | 19.4 |
| Gross margin | 17.2% | 23.8% | 23.8% | 18.4% | 9.2% | 29.8% |
| Selling, general and administrative | 10.9 | 11.7 | 14.5 | 18.1 | 17.8 | 18.2 |
| Research and development | 0.0 | 0.2 | 0.8 | 1.3 | | |
| Other operating expenses | | -5.5 | -0.4 | -4.5 | 5.7 | -6.0 |
| EBITDA [+] | -7.9 | -0.4 | 0.2 | 1.5 | -15.6 | 9.0 |
| EBITDA growth | 2147.7% | -278.6% | -86.6% | -109.4% | -272.5% | |
| EBITDA margin | -54.0% | -1.6% | 0.3% | 1.8% | -22.3% | 13.9% |
| Depreciation | 0.4 | 0.7 | 0.8 | 1.7 | 1.5 | 1.9 |
| EBITA | -8.3 | -1.1 | -0.6 | -0.2 | -17.1 | 7.2 |
| EBITA margin | -56.9% | -4.8% | -1.0% | -0.3% | -24.4% | 11.0% |
| Amortization of intangibles | 0.1 | 0.1 | 0.2 | | | |
| EBIT [+] | -8.4 | -1.2 | -0.8 | -0.2 | -17.1 | 7.2 |
| EBIT growth | 625.8% | 36.9% | 264.9% | -98.6% | -338.1% | |
| EBIT margin | -57.4% | -5.2% | -1.4% | -0.3% | -24.4% | 11.0% |
| Non-recurring items [+] | | 5.4 | | 2.6 | -7.7 | |
| Loss (gain) on sale of assets | | 5.4 | | 2.6 | -7.7 | |
| Interest expense | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 |
| Interest expense | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 |
| Other income (expense), net [+] | 0.0 | 0.0 | 0.0 | 0.0 | -1.3 | -1.2 |
| Gain (loss) on debt retirement | | 0.0 | 0.4 | 1.9 | | |
| Gain (loss) on foreign currency transactions | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | |
| Other | -0.1 | -0.1 | -0.1 | -0.2 | | -0.4 |
| Pre-tax income | -8.5 | -6.7 | -1.0 | -3.0 | -10.9 | 5.7 |
| Income taxes | 0.0 | -2.0 | -0.9 | -1.1 | -5.6 | 1.0 |
| Tax rate | 0.0% | 29.0% | 91.2% | 37.7% | 51.6% | 16.6% |
| Minority interest | 0.0 | | | | | |
| Earnings from continuing ops | -8.5 | -6.6 | -0.1 | -1.9 | -8.7 | 5.5 |
| Earnings from discontinued ops | | | | | 3.4 | -0.7 |
| Net income | -8.5 | -6.6 | -0.1 | -1.9 | -5.3 | 4.8 |
| Net margin | -58.1% | -30.0% | -0.1% | -2.4% | -7.6% | 7.4% |
| |
| Basic EPS [+] | ($0.92) | ($0.77) | ($0.01) | ($0.23) | ($1.04) | $0.65 |
| Growth | 19.4% | 7444.0% | -95.5% | -78.1% | -258.7% | |
| Diluted EPS [+] | ($0.92) | ($0.77) | ($0.01) | ($0.23) | ($1.04) | $0.65 |
| Growth | 19.4% | 7444.0% | -95.5% | -78.1% | -258.7% | |
| |
| Shares outstanding (basic) [+] | 9.2 | 8.6 | 8.4 | 8.3 | 8.3 | 8.3 |
| Growth | 7.0% | 2.3% | 0.5% | 0.1% | 0.1% | |
| Shares outstanding (diluted) [+] | 9.2 | 8.6 | 8.4 | 8.3 | 8.3 | 8.3 |
| Growth | 7.0% | 2.3% | 0.5% | 0.1% | 0.1% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |